Groupe Choc, Contrat Avenir INSERM, Faculté de Médecine, Nancy-Université, Nancy, France.
Intensive Care Med. 2011 Nov;37(11):1857-64. doi: 10.1007/s00134-011-2327-9. Epub 2011 Aug 18.
To compare the effects of recombinant human activated protein C (APC) and glucocorticoids alone and in combination in non-anesthetized resuscitated septic shock induced by cecal ligation and puncture (CLP) on (a) survival, (b) hemodynamics, and (c) vascular reactivity. The effects of treatments on major cellular pathways likely implicated were also studied.
Four hours after CLP, rats were continuously infused with either saline (10 ml/kg/h), saline + APC, saline + dexamethasone (Dexa), or saline + APC + Dexa. Eighteen hours after CLP, arterial pressure, cardiac output, nitrite/nitrate ratio, and lactate concentrations were measured. Aortic rings and mesenteric arteries were isolated and mounted in a myograph, after which arterial contractility and endothelium-dependent relaxation were measured in the presence or absence of nitric oxide synthase (NOS) or cyclooxygenase (COX) inhibitors. Protein expression was assessed by Western blotting. Aorta NO and superoxide anion content were measured by electron paramagnetic resonance.
All treatments improved hemodynamic parameters and vascular reactivity and decreased lactate and nitrite/nitrate levels. In treated aorta and mesenteric arteries, contractility and endothelial dysfunction were improved. This effect was associated with an increase in the phosphorylated form of protein kinase B as well as an increase in COX vasodilatory pathways and a decrease in iNOS expression suggesting that these pathways are implicated in the vascular effect of the treatments. CLP was associated with a marked increase in aortic NO and superoxide anion content (p < 0.05), which were decreased by APC and Dexa and totally abolished by APC + Dexa (p < 0.01). Survival length was significantly increased by the APC-Dexa combination.
Both APC and Dexa improve arterial contractility and endothelial dysfunction resulting from septic shock in rats. Moreover, their combination increased the length of survival. These findings provide important insights into the mechanisms underlying APC- and/or Dexa-induced improvements of arterial dysfunction during septic shock.
比较重组人激活蛋白 C(APC)和单独使用糖皮质激素以及联合使用这两种药物对盲肠结扎穿刺(CLP)诱导的非麻醉性复苏性脓毒性休克的影响,(a)存活率,(b)血流动力学和(c)血管反应性。还研究了治疗对可能涉及的主要细胞途径的影响。
CLP 后 4 小时,大鼠连续输注生理盐水(10 ml/kg/h)、生理盐水+APC、生理盐水+地塞米松(Dexa)或生理盐水+APC+Dexa。CLP 后 18 小时,测量动脉压、心输出量、亚硝酸盐/硝酸盐比值和乳酸浓度。分离并在肌动描记器中安装主动脉环和肠系膜动脉,然后在存在或不存在一氧化氮合酶(NOS)或环氧化酶(COX)抑制剂的情况下测量动脉收缩性和内皮依赖性松弛性。通过 Western blot 评估蛋白质表达。通过电子顺磁共振测量主动脉 NO 和超氧阴离子含量。
所有治疗均改善了血流动力学参数和血管反应性,并降低了乳酸和亚硝酸盐/硝酸盐水平。在治疗的主动脉和肠系膜动脉中,收缩性和内皮功能障碍得到改善。这种作用与蛋白激酶 B 的磷酸化形式增加以及 COX 血管扩张途径增加和 iNOS 表达减少有关,这表明这些途径与治疗的血管作用有关。CLP 与主动脉 NO 和超氧阴离子含量的显著增加有关(p <0.05),APC 和 Dexa 降低了这些含量,而 APC+Dexa 则完全消除了这些含量(p <0.01)。APC+Dexa 联合治疗显著增加了存活时间。
APC 和 Dexa 均可改善大鼠脓毒性休克引起的动脉收缩性和内皮功能障碍。此外,它们的联合使用增加了存活时间。这些发现为 APC 和/或 Dexa 诱导的脓毒性休克期间动脉功能障碍改善的机制提供了重要的见解。